The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Zhukova N.G.

Siberian State Medical University

Kicherov N.A.

Siberian State Medical University» Ministry of Health of Russia

Semykin M.E.

Siberian State Medical University» Ministry of Health of Russia

Gustatory disorders in COVID-19

Authors:

Zhukova N.G., Kicherov N.A., Semykin M.E.

More about the authors

Read: 4019 times


To cite this article:

Zhukova NG, Kicherov NA, Semykin ME. Gustatory disorders in COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(12):23‑31. (In Russ.)
https://doi.org/10.17116/jnevro202212212123

Recommended articles:
Diffuse changes in the brain in the acute phase of COVID-19 and after infe­ction. Russian Journal of Archive of Pathology. 2025;(1):5-15
Liver pathology in COVID-19. Russian Journal of Archive of Pathology. 2025;(1):53-59
mRNA cancer vaccines: features of problems and collisions. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(1):3-16
SpO2/RR index in choosing the method for correction of acute respiratory failure in COVID-19 patients. Russian Journal of Anesthesiology and Reanimatology. 2025;(2):50-58

References:

  1. Tsuchiya H. Oral Symptoms Associated with COVID-19 and Their Pathogenic Mechanisms: A Literature Review. Dentistry Journal. 2021;9(3):32.  https://doi.org/10.3390/dj9030032
  2. Rojas-Lechuga MJ, Izquierdo-Domínguez A, Chiesa-Estomba C, et al. Chemosensory dysfunction in COVID-19 out-patients. Eur Arch Otorhinolaryngol. 2021;278(3):695-702.  https://doi.org/10.1007/s00405-020-06266-3
  3. Printza A, Katotomichelakis M, Valsamidis K, et al. Smell and Taste Loss Recovery Time in COVID-19 Patients and Disease Severity. J Clin Med. 2021;10(5):966.  https://doi.org/10.3390/jcm10050966
  4. Amorim Dos Santos J, Normando AGC, Carvalho da Silva RL, et al. Oral Manifestations in Patients with COVID-19: A Living Systematic Review. J Dent Res. 2021;100(2):141-154.  https://doi.org/10.1177/0022034520957289
  5. Salmon Ceron D, Bartier S, Hautefort C, et al. Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter Coranosmia cohort study. J Infect. 2020;81(4):614-620.  https://doi.org/10.1016/j.jinf.2020.07.005
  6. Giacomelli A, Pezzati L, Conti F, et al. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020;71(15):889-890.  https://doi.org/10.1093/cid/ciaa330
  7. Vaira LA, Deiana G, Fois AG, et al. Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases. Head Neck. 2020;42(6):1252-1258. https://doi.org/10.1002/hed.26204
  8. Sakalli E, Temirbekov D, Bayri E, et al. Ear nose throat-related symptoms with a focus on loss of smell and/or taste in COVID-19 patients. Am J Otolaryngol. 2020;41(6):102622. https://doi.org/10.1016/j.amjoto.2020.102622
  9. Paderno A, Schreiber A, Grammatica A, et al. Smell and taste alterations in COVID-19: a cross-sectional analysis of different cohorts. Int Forum Allergy Rhinol. 2020;10(8):955-962.  https://doi.org/10.1002/alr.22610
  10. Pérula de Torres LÁ, González-Lama J, Jiménez García C, et al. Frequency and predictive validity of olfactory and taste dysfunction in patients with SARS-CoV-2 infection. Frecuencia de aparición y validez predictiva de la disfunción olfatoria y del gusto en pacientes con infección por SARS-CoV-2. Med Clin (Barc). 2021;156(12):595-601.  https://doi.org/10.1016/j.medcli.2020.12.015
  11. Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251-2261. https://doi.org/10.1007/s00405-020-05965-1
  12. Lee Y, Min P, Lee S, Kim SW. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients. J Korean Med Sci. 2020;35(18):e174. https://doi.org/10.3346/jkms.2020.35.e174
  13. Chary E, Carsuzaa F, Trijolet JP, et al. Prevalence and Recovery From Olfactory and Gustatory Dysfunctions in Covid-19 Infection: A Prospective Multicenter Study. Am J Rhinol Allergy. 2020;34(5):686-693.  https://doi.org/10.1177/1945892420930954
  14. Agyeman AA, Chin KL, Landersdorfer CB, et al. Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis. Mayo Clin Proc. 2020;95(8):1621-1631. https://doi.org/10.1016/j.mayocp.2020.05.030
  15. Brandão Neto D, Fornazieri MA, Dib C, et al. Chemosensory Dysfunction in COVID-19: Prevalences, Recovery Rates, and Clinical Associations on a Large Brazilian Sample. Otolaryngol Head Neck Surg. 2021;164(3):512-518.  https://doi.org/10.1177/0194599820954825
  16. Cho RHW, To ZWH, Yeung ZWC, et al. COVID-19 Viral Load in the Severity of and Recovery From Olfactory and Gustatory Dysfunction. Laryngoscope. 2020;130(11):2680-2685. https://doi.org/10.1002/lary.29056
  17. Mercante G, Ferreli F, De Virgilio A, et al. Prevalence of Taste and Smell Dysfunction in Coronavirus Disease 2019. JAMA Otolaryngol Head Neck Surg. 2020;146(8):723-728.  https://doi.org/10.1001/jamaoto.2020.1155
  18. Dudine L, Canaletti C, Giudici F, et al. Investigation on the Loss of Taste and Smell and Consequent Psychological Effects: A Cross-Sectional Study on Healthcare Workers Who Contracted the COVID-19 Infection. Front Public Health. 2021;9:666442. https://doi.org/10.3389/fpubh.2021.666442
  19. Abalo-Lojo JM, Pouso-Diz JM, Gonzalez F. Taste and Smell Dysfunction in COVID-19 Patients. Annals of Otology, Rhinology & Laryngology. 2020;129(10):1041-1042. https://doi.org/10.1177/0003489420932617
  20. Wong DKC, Gendeh HS, Thong HK, et al. A review of smell and taste dysfunction in COVID-19 patients. Med J Malaysia. 2020;75(5):574-581.  https://pubmed.ncbi.nlm.nih.gov/32918429/
  21. Meini S, Suardi LR, Busoni M, et al. Olfactory and gustatory dysfunctions in 100 patients hospitalized for COVID-19: sex differences and recovery time in real-life. Eur Arch Otorhinolaryngol. 2020;277(12):3519-3523. https://doi.org/10.1007/s00405-020-06102-8
  22. Yoshimura K, Toya S, Okada Y. Morphological Analysis of Angiotensin-Converting Enzyme 2 Expression in the Salivary Glands and Associated Tissues. Journal of Hard Tissue Biology. 2021;30(3):265-272.  https://doi.org/10.2485/jhtb.30.265
  23. Okada Y, Yoshimura K, Toya S, Tsuchimochi M. Pathogenesis of taste impairment and salivary dysfunction in COVID-19 patients. Jpn Dent Sci Rev. 2021;57:111-122.  https://doi.org/10.1016/j.jdsr.2021.07.001
  24. Riestra-Ayora J, Yanes-Diaz J, Esteban-Sanchez J, et al. Long-term follow-up of olfactory and gustatory dysfunction in COVID-19: 6 months case-control study of health workers. Eur Arch Otorhinolaryngol. 2021;278(12):4831-4837. https://doi.org/10.1007/s00405-021-06764-y
  25. Cooper KW, Brann DH, Farruggia MC, et al. COVID-19 and the Chemical Senses: Supporting Players Take Center Stage. Neuron. 2020;107(2):219-233.  https://doi.org/10.1016/j.neuron.2020.06.032
  26. Singer-Cornelius T, Cornelius J, Oberle M, et al. Objective gustatory and olfactory dysfunction in COVID-19 patients: a prospective cross-sectional study. Eur Arch Otorhinolaryngol. 2021;278(9):3325-3332. https://doi.org/10.1007/s00405-020-06590-8
  27. Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. International Journal of Oral Science. 2020;12(1):8.  https://doi.org/10.1038/s41368-020-0074-x
  28. Xu R, Cui B, Duan X, et al. Saliva: potential diagnostic value and transmission of 2019-nCoV. International Journal of Oral Science. 2020;12(1):11.  https://doi.org/10.1038/s41368-020-0080-z
  29. Han Q, Peng J, Xu H, Chen Q. Taste Cell Is Abundant in the Expression of ACE2 Receptor of 2019-nCoV. ww.wpreprints.org. Preprints 2020, 2020040424. https://doi.org/10.20944/preprints202004.0424.v1
  30. Hamming I, Timens W, Bulthuis ML, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631-637.  https://doi.org/10.1002/path.1570
  31. Amraei R, Rahimi N. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction. Cells. 2020;9(7):1652. https://doi.org/10.3390/cells9071652
  32. Bourgonje AR, Abdulle AE, Timens W, et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol. 2020;251(3):228-248.  https://doi.org/10.1002/path.5471
  33. Heurich A, Hofmann-Winkler H, Gierer S, et al. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol. 2014;88(2):1293-1307. https://doi.org/10.1128/JVI.02202-13
  34. Sawa Y, Ibaragi S, Okui T, et al. Expression of SARS-CoV-2 entry factors in human oral tissue. J Anat. 2021;238(6):1341-1354. https://doi.org/10.1111/joa.13391
  35. Sakaguchi W, Kubota N, Shimizu T, et al. Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity. International Journal of Molecular Sciences. 2020;21(17):34-37.  https://doi.org/10.3390/ijms21176000
  36. Ou X, Liu Y, Lei X, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020;11(1):1620. https://doi.org/10.1038/s41467-020-15562-9
  37. Darbani B. The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues. International Journal of Environmental Research and Public Health. 2020;17(10):3433. https://doi.org/10.3390/ijerph17103433
  38. Moulard M, Decroly E. Maturation of HIV envelope glycoprotein precursors by cellular endoproteases. Biochimica et Biophysica Acta (BBA) — Reviews on Biomembranes. 2000;1469(3):121-132.  https://doi.org/10.1016/S0304-4157(00)00014-9
  39. Coutard B, Valle C, de Lamballerie X, et al. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. 2020;176:104742. https://doi.org/10.1016/j.antiviral.2020.104742
  40. Jothimani D, Kailasam E, Danielraj S, et al. COVID-19: Poor outcomes in patients with zinc deficiency. Int J Infect Dis. 2020;100:343-349.  https://doi.org/10.1016/j.ijid.2020.09.014
  41. Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-690.  https://doi.org/10.1001/jamaneurol.2020.1127

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.